Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Neonatal Pneumothorax: A Descriptive Regional Danish Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Improving the cost-effectiveness of laypersons' paediatric basic life support skills training: A randomised non-inferiority study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Assessment of laypersons' paediatric basic life support and foreign body airway obstruction management skills: a validity study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Anna-Karin Edstedt Bonamy
  • Anna Gudmundsdottir
  • Rolf F Maier
  • Liis Toome
  • Jennifer Zeitlin
  • Mercedes Bonet
  • Alan Fenton
  • Asbjørn Børch Hasselager
  • Arno van Heijst
  • Ludwig Gortner
  • David Milligan
  • Patrick Van Reempts
  • Elaine M Boyle
  • Mikael Norman
  • and collaborators from the EPICE Research Group
Vis graf over relationer

BACKGROUND: Spontaneous closure of patent ductus arteriosus (PDA) occurs frequently in very preterm infants and despite the lack of evidence for treatment benefits, treatment for PDA is common in neonatal medicine.

OBJECTIVES: The aim of this work was to study regional variations in PDA treatment in very preterm infants (≤31 weeks of gestation), its relation to differences in perinatal characteristics, and associations with bronchopulmonary dysplasia (BPD) and survival without major neonatal morbidity.

METHODS: This was a population-based cohort study in 19 regions in 11 European countries conducted during 2011 and 2012. A total of 6,896 infants with data on PDA treatment were included. The differences in infant characteristics were studied across regions using a propensity score derived from perinatal risk factors for PDA treatment. The primary outcomes were a composite of BPD or death before 36 weeks postmenstrual age, or survival without major neonatal morbidity.

RESULTS: The proportion of PDA treatment varied from 10 to 39% between regions (p < 0.001), and this difference could not be explained by differences in perinatal characteristics. The regions were categorized according to a low (<15%, n = 6), medium (15-25%, n = 9), or high (>25%, n = 4) proportion of PDA treatment. Infants treated for PDA, compared to those not treated, were at higher risk of BPD or death in all regions, with an overall propensity score adjusted risk ratio of 1.33 (95% confidence interval 1.18-1.51). Survival without major neonatal morbidity was not related to PDA treatment.

CONCLUSIONS: PDA treatment varies largely across Europe without associated variations in perinatal characteristics or neonatal outcomes. This finding calls for more uniform guidance for PDA diagnosis and treatment in very preterm infants.

OriginalsprogEngelsk
TidsskriftNeonatology
Vol/bind111
Udgave nummer4
Sider (fra-til)367-375
Antal sider9
ISSN1661-7800
DOI
StatusUdgivet - 26 jan. 2017

ID: 49763041